hwkn-20211027
0000046250FALSE00000462502021-10-272021-10-27

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 27, 2021
  
Hawkins, Inc.
(Exact name of registrant as specified in its charter)
 
Minnesota 0-7647 41-0771293
(State of Incorporation) (Commission File Number) (IRS Employer Identification No.)
2381 Rosegate,Roseville,Minnesota55113
(Address of Principal Executive Offices)(Zip Code)

Registrant’s Telephone Number, Including Area Code (612331-6910
  
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $.01 per share
HWKN
Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (17 CFR 230.405) or Rule 12b-2 of the Exchange Act (17 CFR 240.12b 2).

Emerging growth company ¨
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨




Item 2.02. Results of Operations and Financial Condition.
On October 27, 2021, Hawkins, Inc. issued a press release announcing financial results for its fiscal 2022 second quarter ended September 26, 2021. A copy of the press release issued by the Registrant is furnished herewith as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.
(d)Exhibits.
Exhibit No.  Description  Method of Filing
  
Press Release, dated October 27, 2021, announcing financial results of Hawkins, Inc. for its fiscal 2022 second quarter ended September 26, 2021.
  Filed Electronically
104 Cover Page Interactive Data File (embedded within the inline XBRL document)Filed Electronically




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 HAWKINS, INC.
Date: October 27, 2021
 By: /s/ Jeffrey P. Oldenkamp
  Jeffrey P. Oldenkamp
  Executive Vice President and Chief Financial Officer


Document

Exhibit 99.1
October 27, 2021
Hawkins, Inc.
2381 Rosegate
Roseville, MN 55113
Hawkins, Inc. Reports
Second Quarter Fiscal 2022 Results

Minneapolis, MN, October 27, 2021 – Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three and six months ended September 26, 2021, its second quarter of fiscal 2022. Highlights include:

Record quarterly sales of $183.3 million, a 24% year-over-year increase, with increases in all three segments.
Record second quarter gross profit of $37.3 million, a 14% increase over the prior year, contributing to record second quarter operating income of $19.6 million, a 18% year-over-year increase.
Record second quarter diluted earnings per share (EPS) of $0.67, which was $0.10, or 18%, higher than the same period last year.
Record quarterly operating cash flow of $25.3 million, compared to $18.6 million a year ago, allowing continued repayment of debt, with its leverage ratio under 1.0x at quarter end.
Record second quarter earnings before interest, taxes, depreciation and amortization (EBITDA), a non-GAAP measure, of $26.6 million, a 14% increase over the prior year.
Completed the acquisition of Southeast Water Systems in Alabama in September, as previously announced.
Year-to-date operating income, net income and diluted EPS each increased 28% over the prior year.

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

“We are pleased with our continued strong operating results in fiscal 2022, with record quarterly sales of $183 million contributing to an 18% increase in operating income over the prior year. Significant revenue growth in both our Industrial and Water Treatment segments was driven by increased sales volumes of many of our products and increased selling prices due to rising raw material costs. As a result of rising raw material costs, in the quarter we recorded a LIFO charge of $3 million, and nearly $5 million in the first six months of fiscal 2022, negatively impacting our gross profit. Even with this significant negative impact of LIFO, we were still able to grow our gross profit by 20% in both our Water Treatment and Industrial segments."

Mr. Hawkins continued, "Demand for products in our Health and Nutrition group remained steady in the second quarter, due to continued consumer focus on health and immunity products. In addition, like many industries, we have experienced supply chain challenges in each of our business segments and expect those supply chain challenges to continue. However, thanks to the efforts of our outstanding employees, the relationships we have with our vendors and the investments we have made in storage and infrastructure, we have been able to overcome these challenges and continue to serve our customers."

Second Quarter Financial Highlights:

Sales were $183.3 million for the second quarter of fiscal 2022, an increase of 24%, from sales of $147.8 million for the same period a year ago. Industrial segment sales increased $22.0 million, or 36%, to $83.2 million for the current quarter, from $61.2 million for the same period a year ago. The increase in Industrial sales was driven by increased sales of both our bulk products as well as our manufactured, blended and repackaged products, in particular certain of our agricultural and food ingredient products. Water Treatment segment sales increased $12.6 million, or 25%, to $62.1 million for the current quarter, from $49.5 million for the same period a year ago. Water Treatment sales increased as a result of increased demand for many of our products, as well as $4.9 million in added sales from the acquisitions of ADC and C&L Aqua in fiscal 2021. Sales for our Health and Nutrition segment increased $0.9 million, or 2%, to $38.0 million for the current quarter, from $37.1 million for the same period a year ago. The increase in Health and Nutrition sales was driven by increased sales of our specialty distributed products largely as a result of continued increased demand for ingredients used in health and immunity products.



Gross profit increased $4.5 million, or 14%, to $37.3 million, or 20% of sales, for the current quarter, from $32.8 million, or 22% of sales, for the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $3.0 million, primarily due to rising raw material prices. In the same quarter a year ago, the LIFO reserve increased, and gross profit decreased, by $0.2 million. Gross profit for the Industrial segment increased $2.2 million, or 20%, to $12.6 million, or 15% of sales, for the current quarter, from $10.4 million, or 17% of sales, for the same period a year ago. Total Industrial segment gross profit increased as a result of the increase in sales, partially offset by the negative $2.5 million year-over-year impact of the increase in the LIFO reserve. Gross profit for the Water Treatment segment increased $3.0 million or 21% to $17.5 million, or 28% of sales, for the current quarter, from $14.5 million, or 29% of sales, for the same period a year ago. Gross profit in our Water Treatment segment increased as a result of increased sales, including the added sales in the acquired businesses of ADC and C&L Aqua. Gross profit for our Health and Nutrition segment decreased $0.6 million, or 8%, to $7.2 million, or 19% of sales, for the current quarter, from $7.8 million, or 21% of sales, for the same period a year ago. The gross profit decline in our Health and Nutrition segment was a result of product mix changes as well as inventory adjustments of $1.0 million due to increased reserves for excess product on hand, in accordance with our reserve policies.

Company-wide selling, general and administrative expenses increased $1.5 million to $17.7 million, or 10% of sales, for the current quarter, compared to $16.2 million, or 11% of sales, for the same period a year ago. Expenses increased in part due to the added costs from the acquired businesses of ADC and C&L Aqua, including $0.3 million of expense for amortization of intangibles, as well as increased variable pay expense.

Our effective income tax rate was 27% for the current quarter, compared to 26% in the same period a year ago. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes. Our effective tax rate for the full year is currently expected to be approximately 26-27%.

Earnings before interest, taxes, depreciation and amortization ("EBITDA"), a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of EBITDA is presented below. EBITDA for the three months ended September 26, 2021 was $26.6 million, an increase of $3.2 million, or 14%, from EBITDA of $23.4 million for the same period a year ago. The increase was primarily due to improved gross profit.

About Hawkins, Inc.

Hawkins, Inc. was founded in 1938 and is a leading specialty chemical and ingredients company that formulates, distributes, blends, and manufactures products for its Industrial, Water Treatment, and Health & Nutrition customers. Headquartered in Roseville, Minnesota, and with 45 facilities in 23 states, the Company creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated $597 million of revenue in fiscal 2021 and has approximately 750 employees. For more information, including registering to receive email alerts, please visit www.hawkinsinc.com/investors.

Reconciliation of Non-GAAP Financial Measures
We report our consolidated financial results in accordance with U.S. generally accepted accounting principles (GAAP). To assist investors in understanding our financial performance between periods, we have provided certain financial measures not computed according to GAAP, including adjusted EBITDA. This non-GAAP financial measure is not meant to be considered in isolation or as a substitute for comparable GAAP measures. The method we use to produce non-GAAP results is not computed according to GAAP and may differ from the methods used by other companies.
Management uses this non-GAAP financial measure internally to understand, manage and evaluate our business and to make operating decisions. Management believes that this non-GAAP financial measure reflects an additional way of viewing aspects of our operations that, when viewed with our GAAP results, provides a more complete understanding of the factors and trends affecting our financial condition and results of operations.
We define adjusted EBITDA as GAAP net income adjusted for the impact of the following: net interest expense resulting from our net borrowing position; income tax expense; non-cash expenses including amortization of intangibles, depreciation and charges for the employee stock purchase plan and restricted stock grants; and non-recurring items of income or expense, if applicable.




Adjusted EBITDAThree Months EndedSix months ended
(In thousands)September 26, 2021September 27, 2020September 26, 2021September 27, 2020
Net Income (GAAP)$14,133 $12,190 $30,761 $23,978 
Interest expense, net329 339 678 719 
Income tax expense5,330 4,374 10,703 8,621 
Amortization of intangibles1,551 1,447 3,132 2,715 
Depreciation expense4,403 4,134 8,757 8,350 
Non-cash compensation expense862 686 1,661 1,386 
Non-recurring acquisition expenses 265 11 265 
Adjusted EBITDA$26,617 $23,435 $55,703 $46,034 





 
HAWKINS, INC.
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
(In thousands, except share and per-share data)
Three Months EndedSix Months Ended
September 26, 2021September 27, 2020September 26, 2021September 27, 2020
Sales$183,277 $147,801 $364,518 $290,973 
Cost of sales(145,990)(115,004)(288,257)(227,200)
Gross profit37,287 32,797 76,261 63,773 
Selling, general and administrative expenses(17,679)(16,221)(34,535)(31,259)
Operating income19,608 16,576 41,726 32,514 
Interest expense, net(329)(339)(678)(719)
Other income184 327 416 804 
Income before income taxes19,463 16,564 41,464 32,599 
Income tax expense(5,330)(4,374)(10,703)(8,621)
Net income$14,133 $12,190 $30,761 $23,978 
Weighted average number of shares outstanding - basic20,986,542 21,055,782 21,010,422 21,053,022 
Weighted average number of shares outstanding - diluted21,140,087 21,245,762 21,168,809 21,268,562 
Basic earnings per share$0.67 $0.58 $1.46 $1.14 
Diluted earnings per share$0.67 $0.57 $1.45 $1.13 
Cash dividends declared per common share$0.13000 $0.11625 $0.25250 $0.23250 
 






HAWKINS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In thousands, except share data)
September 26,
2021
March 28,
2021
ASSETS
CURRENT ASSETS:
Cash and cash equivalents$6,802 $2,998 
Trade accounts receivables, net90,057 90,603 
Inventories70,338 63,864 
Income taxes receivable— 175 
Prepaid expenses and other current assets2,478 5,367 
Total current assets169,675 163,007 
PROPERTY, PLANT, AND EQUIPMENT:307,021 300,404 
Less accumulated depreciation163,910 155,792 
Net property, plant, and equipment143,111 144,612 
OTHER ASSETS:
Right-of-use assets11,045 11,630 
Goodwill72,417 70,720 
Intangible assets, net of accumulated amortization73,666 76,368 
Other7,890 6,213 
Total other assets165,018 164,931 
Total assets$477,804 $472,550 
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable — trade$43,004 $37,313 
Accrued payroll and employee benefits12,417 18,048 
Income tax payable877 — 
Current portion of long-term debt9,907 9,907 
Short-term lease liability1,625 1,587 
Container deposits1,528 1,452 
Other current liabilities2,191 2,155 
Total current liabilities71,549 70,462 
LONG-TERM DEBT, LESS CURRENT PORTION73,891 88,845 
LONG-TERM LEASE LIABILITY9,553 10,231 
PENSION WITHDRAWAL LIABILITY4,455 4,631 
DEFERRED INCOME TAXES24,445 24,445 
DEFERRED COMPENSATION LIABILITY8,289 7,322 
OTHER LONG-TERM LIABILITIES1,309 1,368 
Total liabilities193,491 207,304 
COMMITMENTS AND CONTINGENCIES— — 
SHAREHOLDERS’ EQUITY:
Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,888,923 and 20,969,746 shares issued and outstanding as of September 26, 2021 and March 28, 2021, respectively
209 210 
Additional paid-in capital44,801 51,138 
Retained earnings239,303 213,898 
Total shareholders’ equity284,313 265,246 
Total liabilities and shareholders’ equity$477,804 $472,550 




HAWKINS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
 
 Six Months Ended
 September 26,
2021
September 27,
2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income$30,761 $23,978 
Reconciliation to cash flows:
Depreciation and amortization11,889 11,065 
Operating leases948 963 
Gain on deferred compensation assets(416)(804)
Stock compensation expense1,661 1,386 
Other54 135 
Changes in operating accounts providing (using) cash:
Trade receivables596 (5,811)
Inventories(6,458)(8,004)
Accounts payable5,116 (1,421)
Accrued liabilities(5,392)(2,320)
Lease liabilities(991)(963)
Income taxes1,053 792 
Other1,261 1,142 
Net cash provided by operating activities40,082 20,138 
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant, and equipment(6,904)(8,120)
Acquisitions(1,200)(25,000)
Other 181 105 
Net cash used in investing activities(7,923)(33,015)
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash dividends declared and paid(5,356)(4,959)
New shares issued889 773 
Shares surrendered for payroll taxes(1,467)(54)
Shares repurchased(7,421)— 
Net (payments on) proceeds from revolving loan(15,000)16,000 
Net cash (used in) provided by financing activities(28,355)11,760 
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS3,804 (1,117)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD2,998 4,277 
CASH AND CASH EQUIVALENTS, END OF PERIOD$6,802 $3,160 
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for income taxes$9,650 $7,845 
Cash paid for interest$563 $610 
Noncash investing activities - capital expenditures in accounts payable$1,076 $191 




HAWKINS, INC.
REPORTABLE SEGMENTS (UNAUDITED)
(In thousands)

IndustrialWater
Treatment
Health and NutritionTotal
Three months ended September 26, 2021:
Sales$83,168 $62,111 $37,998 $183,277 
Gross profit12,564 17,518 7,205 37,287 
Selling, general, and administrative expenses6,456 7,405 3,818 17,679 
Operating income6,108 10,113 3,387 19,608 
Three months ended September 27, 2020:
Sales$61,171 $49,540 $37,090 $147,801 
Gross profit10,436 14,522 7,839 32,797 
Selling, general, and administrative expenses6,429 5,573 4,219 16,221 
Operating income 4,007 8,949 3,620 16,576 
Six months ended September 26, 2021:
Sales$169,018 $118,349 $77,151 $364,518 
Gross profit26,818 33,752 15,691 76,261 
Selling, general and administrative expenses12,697 14,467 7,371 34,535 
Operating income14,121 19,285 8,320 41,726 
Six months ended September 27, 2020:
Sales$132,673 $89,254 $69,046 $290,973 
Gross profit22,893 25,861 15,019 63,773 
Selling, general and administrative expenses12,496 10,866 7,897 31,259 
Operating income 10,397 14,995 7,122 32,514 



Forward-Looking Statements. Various remarks in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include those relating to consumer demand for products containing our ingredients and the impacts of those demands, expectations for results in our business segments and the timing of our filings with the Securities and Exchange Commission. These statements are not historical facts, but rather are based on our current expectations, estimates and projections, and our beliefs and assumptions. Forward-looking statements may be identified by terms, including “anticipate,” “believe,” “can,” “could,” “expect,” “intend,” “may,” “predict,” “should,” or “will” or the negative of these terms or other comparable terms. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. Actual results may vary materially from those contained in forward looking statements based on a number of factors, including, but not limited to, the impact and severity of the COVID-19 outbreak, changes in the labor markets, our available cash for investments, our business capital needs, changes in competition and price pressure, changes in demand and customer requirements or processes for our products, interruptions in production resulting from hazards, transportation limitations or other extraordinary events outside our control that may negatively impact our business or the supply chains in which we participate, our ability to locate suitable real estate for new branch additions, changes in imported products and tariff levels, the availability of products and the prices at which they are available, the acceptance of new products by our customers and the timing of any such acceptance, and changes in product supplies. Additional information concerning potential factors that could affect future financial results is included in our Annual Report on Form 10-K for the fiscal year ended March 28, 2021, as updated from time to time in amendments and subsequent reports filed with the SEC. Investors should take such risks into account when making investment decisions. Shareholders and other readers are cautioned not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date hereof. We do not undertake any obligation to update any forward-looking statements.

Contacts:    Jeffrey P. Oldenkamp
Executive Vice President and Chief Financial Officer
612/331-6910
ir@HawkinsInc.com